Lebovits Chaim
SEC insider (Form 3/4/5 filer). CIK 0001406302. President & CEO at BRAINSTORM CELL THERAPEUTICS INC. (BCLI). 4 reported Form 4/5 transactions since Sep 2024; latest on Feb 26, 2026. Located in NEW YORK, NY.
Companies Lebovits Chaim has filed insider reports for
- BRAINSTORM CELL THERAPEUTICS INC. (BCLI): Officer, President & CEO
Lebovits Chaim
CIK: 0001406302
Transaction Breakdown
Open Market Buys (P)2 (50.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (50.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
BCLI
BRAINSTORM CELL THERAPEUTICS INC.
Officer
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Feb 26, 2026BCLI
BRAINSTORM CELL THERAPEUTICS INC.
AwardDirect1.8M shares- - Jan 1, 2025BCLI
BRAINSTORM CELL THERAPEUTICS INC.
AwardDirect120K shares- - Oct 1, 2024BCLI
BRAINSTORM CELL THERAPEUTICS INC.
PurchaseDirect1.8K shares at avg. $3.43$6K - Sep 30, 2024BCLI
BRAINSTORM CELL THERAPEUTICS INC.
PurchaseDirect22K shares at avg. $0.23$5K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Feb 26, 2026 | BCLI BRAINSTORM CELL THERAPEUTICS INC. | Award | 1,800,000 | - | $0 | Direct |
| Jan 1, 2025 | BCLI BRAINSTORM CELL THERAPEUTICS INC. | Award | 120,000 | - | $0 | Direct |
| Oct 1, 2024 | BCLI BRAINSTORM CELL THERAPEUTICS INC. | Purchase | 1,836 | $3.43 | $6,292 | Direct |
| Sep 30, 2024 | BCLI BRAINSTORM CELL THERAPEUTICS INC. | Purchase | 22,000 | $0.23 | $5,016 | Direct |
1-4 of 4 transactions